Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2023
  • Volume: 16
  • Issue: 12

A Review on Thiazole derivatives and their impact as hypoglycemic agents in drug developments

  • Author:
  • Dheeraj Rajesh Gupta1,3, Pankaj Kumar1,3,*, Abhishek Kumar1,3, Sachin A Kumbar1,3, Vidya Murugeshwari1,3, Seshagiri R Dixit2
  • Total Page Count: 4
  • Page Number: 6077 to 6080

1Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS)

2JSS College of Pharmacy, Department of Pharmaceutical Chemistry, Mysore, India

3Department of Pharmaceutical Chemistry, Mangalore, India

*Corresponding Author E-mail: pankajpgr@nitte.edu.in

Online Published on 07 February, 2024.

Abstract

The impact of thiazole derivatives as a hypoglycemic agent has been noted for many decades. Thiazole is heterocyclic containing sulphur and nitrogen as heteroatom whereas the free pi (π) electrons can move from one bond to another freely to have aromatic properties. Due to these aromatic properties, various reactions are possible with these rings due to the various donor-acceptor position. Thiazole can regulate various physiochemical processes within the body. Due to this, it has been reported for various biological activities such as antimicrobial, antitumor, antidiabetic, antioxidant, anti-inflammatory etc. However, there are various drugs containing thiazole are rosiglitazone, pioglitazone, and troglitazone have shown their effectiveness in controlling elevated blood sugar. In this regard, the present review explains the different thiazole derivatives synthesized and their impact as hypoglycemic agents.

Keywords

Thiazole, Anti-diabetic, α-Amylase, α-Glucosidase